Old Port Advisors trimmed its holdings in shares of Danaher Co. (NYSE:DHR) by 10.3% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,721 shares of the conglomerate’s stock after selling 198 shares during the quarter. Old Port Advisors’ holdings in Danaher were worth $250,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors have also bought and sold shares of the stock. Northern Trust Corp grew its position in Danaher by 0.4% during the first quarter. Northern Trust Corp now owns 8,887,690 shares of the conglomerate’s stock worth $1,173,352,000 after buying an additional 34,065 shares in the last quarter. Geode Capital Management LLC boosted its holdings in shares of Danaher by 8.4% in the 4th quarter. Geode Capital Management LLC now owns 7,527,142 shares of the conglomerate’s stock worth $774,743,000 after purchasing an additional 583,194 shares in the last quarter. Findlay Park Partners LLP boosted its holdings in shares of Danaher by 0.9% in the 1st quarter. Findlay Park Partners LLP now owns 4,635,000 shares of the conglomerate’s stock worth $611,913,000 after purchasing an additional 40,000 shares in the last quarter. Jennison Associates LLC purchased a new position in shares of Danaher in the 1st quarter worth about $489,930,000. Finally, American Century Companies Inc. boosted its holdings in shares of Danaher by 3.7% in the 1st quarter. American Century Companies Inc. now owns 3,700,569 shares of the conglomerate’s stock worth $488,549,000 after purchasing an additional 133,300 shares in the last quarter. Institutional investors and hedge funds own 78.84% of the company’s stock.
A number of equities analysts have recently issued reports on DHR shares. Royal Bank of Canada set a $134.00 price objective on Danaher and gave the stock a “hold” rating in a report on Friday, July 19th. Argus upped their price objective on Danaher to $165.00 and gave the stock a “buy” rating in a report on Tuesday, July 23rd. Robert W. Baird upped their price objective on Danaher from $131.00 to $148.00 and gave the stock an “outperform” rating in a report on Friday, July 19th. Janney Montgomery Scott upped their price objective on Danaher from $136.00 to $174.00 and gave the stock a “buy” rating in a report on Wednesday, April 17th. Finally, Piper Jaffray Companies upped their price objective on Danaher from $148.00 to $153.00 and gave the stock a “neutral” rating in a report on Thursday, July 18th. Three investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $143.54.
Danaher (NYSE:DHR) last issued its earnings results on Thursday, July 18th. The conglomerate reported $1.19 earnings per share for the quarter, beating the consensus estimate of $1.15 by $0.04. The company had revenue of $5.16 billion during the quarter, compared to analysts’ expectations of $5.09 billion. Danaher had a return on equity of 11.53% and a net margin of 12.22%. Danaher’s quarterly revenue was up 3.5% compared to the same quarter last year. During the same period in the prior year, the business posted $1.15 EPS. As a group, equities analysts predict that Danaher Co. will post 4.79 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which was paid on Friday, July 26th. Shareholders of record on Friday, June 28th were given a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 0.48%. The ex-dividend date of this dividend was Thursday, June 27th. Danaher’s payout ratio is 15.04%.
In other Danaher news, CAO Robert S. Lutz sold 14,668 shares of the company’s stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $143.28, for a total transaction of $2,101,631.04. Following the completion of the transaction, the chief accounting officer now owns 21,054 shares of the company’s stock, valued at approximately $3,016,617.12. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Brian W. Ellis sold 1,010 shares of the company’s stock in a transaction that occurred on Friday, July 26th. The shares were sold at an average price of $144.04, for a total value of $145,480.40. Following the transaction, the insider now directly owns 20,889 shares of the company’s stock, valued at approximately $3,008,851.56. The disclosure for this sale can be found here. Insiders have sold a total of 392,121 shares of company stock valued at $53,603,339 in the last ninety days. 11.40% of the stock is currently owned by corporate insiders.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
See Also: Lock-Up Period Expiration
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.